Imagine diagnosing lung conditions through a simple cough recording—no bulky machines, no costly tests, no clinic visits. That’s possible with Swaasa, an AI-driven respiratory platform.
It combines the power of AI and deep learning to deliver accurate lung health assessments in seconds.
Accessible, affordable, and designed for everyone, Swaasa is redefining how we monitor and manage respiratory health.
Learn how Swaasa is assisting patients and healthcare professionals with its innovative AI.
What is Swaasa?
Swaasa is a respiratory health platform that uses advanced audiometric analysis to diagnose lung conditions.
It analyses cough sounds and key metrics like oxygen saturation and temperature to provide quick and accurate assessments. Swaasa’s analysis helps healthcare providers diagnose, make informed decisions and improve care outcomes.
Its platform complies with HIPAA, CDSCO and ISO standards to ensure patient data privacy and security.
How does Swaasa work?
It’s simple. All you need is a smartphone. Patients record a cough sample in the Swaasa app. The app uses advanced machine learning algorithms to analyze the audio. Abnormalities in cough sounds help detect respiratory ailments like asthma and chronic obstructive pulmonary disease (COPD).
In just 15 seconds, it delivers a detailed assessment of lung health. This assessment enables healthcare professionals to diagnose and recommend treatment immediately.
Swaasa’s technology eliminates the need for in-clinic visits and traditional diagnostic tools like spirometry. Thus, it makes care affordable and accessible—especially in underserved areas.
What makes Swaasa unique?
What sets Swaasa apart is its ML and AI-driven respiratory healthcare system. Traditional diagnostic tools can be expensive and geographically limited.
Swaasa’s solution bridges this gap by offering remote, cost-effective care without compromising accuracy. In fact, they’re the world’s first company to secure a license for audiometric analysis in pulmonary diagnostics, a testament to their innovation.
The app’s user-friendly interface offers detailed, quick, precise, and affordable lung assessments. It costs less than a dollar per test and can be conducted anytime, anywhere.
The app can handle up to 500 million assessments daily with a sub-dollar pricing. This makes Swaasa scalable and affordable to provide advanced diagnostics for a huge population.
A solution designed for everyone
Swaasa offers a myriad of solutions to improve pulmonary healthcare. It caters to a diverse range of users:
- Patients can use its smartphone app to easily monitor their lung health at home with low-cost, user-friendly tools.
- Healthcare professionals can use its integrated telemedicine platform to remotely access quick, precise diagnostic insights. This makes healthcare accessible in areas with limited resources.
- Organizations can proactively monitor employee health, ensuring well-being while protecting privacy.
- Governments and institutions can enhance their healthcare services by integrating Swaasa’s capabilities into their platforms. This ensures more holistic solutions to end customers.
About Swaasa: History and background
Swaasa is Narayana Rao Sripada’s brainchild. He founded the company in 2017 to address the global burden of respiratory diseases. Today, the company’s vision is to become the leader in digital health innovation for respiratory diseases.
By leveraging cutting-edge AI and patented audiometric technology, Swaasa ensures precision, scalability, and accessibility—a rare trifecta in healthcare.
In India, Swaasa has collaborations with prominent names like Apollo 247, Windlass, and Coforge. It has also partnered with government initiatives. Swaasa’s parent company Salcit, has received a grant from the Department of Biotechnology, Government of India, for its impact on community health.
Breathing easier with Swaasa
In a world where respiratory diseases often go undiagnosed due to limited resources, Swaasa is a breath of fresh air. By making advanced pulmonary diagnostics accessible to everyone, it’s not just changing how we detect and manage respiratory conditions—it’s saving lives.
With its blend of innovation, affordability, and accessibility, Swaasa is leading the way in digital respiratory care.
